|
|
Article: Trademark Rights Vs. Gray Market Drug Imports.
- Article from:
- Mondaq Business Briefing
- Article date:
- May 30, 2006
CopyrightCOPYRIGHT 2006 Mondaq Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The prescriptions drug market is changing. The disparity of prescription drug prices among countries, along with a growing concern about the availability of affordable medicine, has catalyzed the sale of lower-priced drugs outside the authorized distribution channels of branded drug companies. These gray market goods, also known as parallel imports, are goods produced under intellectual property rights held by the owner (or its licensee) for legitimate sale in one market that are then diverted and distributed in a second market without the authorization of the intellectual property rights owner.
The legality and status of these imports varies among jurisdictions. ...